BIOLASE Inc
OTC:BIOL
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
BIOLASE Inc
OTC:BIOLQ
|
37 USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.3B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.5B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143.3B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.3B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.7B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.4B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
BIOLASE Inc
Glance View
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. The company is headquartered in Foothill Ranch, California and currently employs 158 full-time employees. The firm develops, manufactures, markets and sells laser systems, which provides helps to dental practitioners and their patients. The Company’s systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. Its Waterlase brand uses a patented combination of water and laser energy and performs using drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. The company offers its diode laser systems to perform soft tissue, pain therapy and cosmetic procedures, including teeth whitening. The company has approximately 301 issued and 38 pending United States and international patents.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for BIOLASE Inc is 34.4%, which is above its 3-year median of 32.8%.
Over the last 3 years, BIOLASE Inc’s Gross Margin has decreased from 37.5% to 34.4%. During this period, it reached a low of 29.8% on Mar 31, 2023 and a high of 44.9% on Mar 31, 2022.
